These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11908921)
1. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites. Wonnacott KM; Bonneau RH Brain Behav Immun; 2002 Apr; 16(2):104-17. PubMed ID: 11908921 [TBL] [Abstract][Full Text] [Related]
2. Stress-induced effects on integral immune components involved in herpes simplex virus (HSV)-specific memory cytotoxic T lymphocyte activation. Bonneau RH Brain Behav Immun; 1996 Jun; 10(2):139-63. PubMed ID: 8811937 [TBL] [Abstract][Full Text] [Related]
3. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope. Bonneau RH; Fu TM; Tevethia SS Virology; 1993 Dec; 197(2):782-7. PubMed ID: 7504370 [TBL] [Abstract][Full Text] [Related]
4. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051 [TBL] [Abstract][Full Text] [Related]
5. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Bonneau RH; Salvucci LA; Johnson DC; Tevethia SS Virology; 1993 Jul; 195(1):62-70. PubMed ID: 7686314 [TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598 [TBL] [Abstract][Full Text] [Related]
7. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690 [TBL] [Abstract][Full Text] [Related]
8. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. Martin S; Rouse BT J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075 [TBL] [Abstract][Full Text] [Related]
10. Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection. Paliard X; Doe B; Selby MJ; Hartog K; Lee AY; Burke RL; Walker CM Virology; 2001 Mar; 282(1):56-64. PubMed ID: 11259190 [TBL] [Abstract][Full Text] [Related]
11. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88. Tengvall S; O'Hagan D; Harandi AM Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020 [TBL] [Abstract][Full Text] [Related]
12. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses. Yasukawa M; Zarling JM J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149 [TBL] [Abstract][Full Text] [Related]
13. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival. Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395 [TBL] [Abstract][Full Text] [Related]
14. Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection. Bonneau RH; Sheridan JF; Feng NG; Glaser R Brain Behav Immun; 1991 Sep; 5(3):274-95. PubMed ID: 1659472 [TBL] [Abstract][Full Text] [Related]
15. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2. Kwant A; Rosenthal KL Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061 [TBL] [Abstract][Full Text] [Related]
16. Role of mucosal immunity in herpes simplex virus infection. Kuklin NA; Daheshia M; Chun S; Rouse BT J Immunol; 1998 Jun; 160(12):5998-6003. PubMed ID: 9637514 [TBL] [Abstract][Full Text] [Related]
17. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476 [TBL] [Abstract][Full Text] [Related]
18. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells. Schrier RD; Ishioka GY; Pizer LI; Moorhead JW J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006 [TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Pack CD; Kumaraguru U; Suvas S; Rouse BT Vaccine; 2005 May; 23(27):3526-34. PubMed ID: 15855011 [TBL] [Abstract][Full Text] [Related]
20. Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo. Nugent CT; McNally JM; Chervenak R; Wolcott RM; Jennings SR Cell Immunol; 1995 Oct; 165(1):55-64. PubMed ID: 7545549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]